HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul G Richardson Selected Research

Biomarkers (Surrogate Marker)

1/2022Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?
1/2022Distinctive Biomarker Features in the Endotheliopathy of COVID-19 and Septic Syndromes.
12/2021Predictive biomarkers with isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma.
12/2018Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma.
8/2014Biomarkers of bone remodeling in multiple myeloma patients to tailor bisphosphonate therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul G Richardson Research Topics

Disease

358Multiple Myeloma
05/2024 - 06/2002
97Neoplasms (Cancer)
04/2024 - 06/2002
26Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
05/2023 - 06/2007
24Disease Progression
10/2023 - 06/2005
23Thrombocytopenia (Thrombopenia)
04/2024 - 12/2005
20Peripheral Nervous System Diseases (PNS Diseases)
01/2021 - 07/2006
15Fatigue
04/2024 - 07/2006
14Neutropenia
04/2024 - 10/2008
12Hematologic Neoplasms (Hematological Malignancy)
11/2023 - 06/2003
10Anemia
08/2023 - 09/2009
9Chromosome Aberrations (Chromosome Abnormalities)
04/2024 - 11/2006
9Waldenstrom Macroglobulinemia (Macroglobulinemia)
06/2016 - 04/2003
7Residual Neoplasm
12/2023 - 10/2016
7Plasmacytoma
09/2023 - 09/2002
6Pneumonia (Pneumonitis)
02/2022 - 01/2019
6Lymphoma (Lymphomas)
01/2021 - 01/2005
6Exanthema (Rash)
01/2018 - 01/2012
6Leukemia
10/2017 - 01/2004
6Inflammation (Inflammations)
01/2017 - 06/2003
5Hemorrhage
01/2022 - 06/2007
4Sepsis (Septicemia)
11/2022 - 12/2019
4COVID-19
02/2022 - 01/2022
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2022 - 09/2003
4Infections
01/2021 - 03/2011
4Necrosis
12/2018 - 04/2005
3Hypotension (Low Blood Pressure)
11/2022 - 03/2016
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 09/2003
3Diarrhea
01/2018 - 03/2017
3Nausea
10/2017 - 07/2006
3Paraproteinemias (Monoclonal Gammopathy)
08/2017 - 09/2008
3Asthenia
06/2016 - 02/2010
3Osteonecrosis (Kienbock's Disease)
08/2014 - 07/2005
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2012 - 02/2005
3Bone Diseases (Bone Disease)
01/2012 - 11/2006
3Human Influenza (Influenza)
03/2011 - 06/2003
3Breast Neoplasms (Breast Cancer)
02/2011 - 04/2005
3Renal Insufficiency (Renal Failure)
11/2010 - 11/2006

Drug/Important Bio-Agent (IBA)

155Bortezomib (Velcade)FDA Link
05/2024 - 09/2002
137Dexamethasone (Maxidex)FDA LinkGeneric
05/2024 - 06/2002
105Lenalidomide (CC 5013)FDA Link
04/2024 - 11/2002
70Proteasome InhibitorsIBA
03/2024 - 06/2002
31pomalidomideIBA
02/2024 - 03/2013
25daratumumabIBA
04/2024 - 06/2015
25Thalidomide (Thalomid)FDA Link
01/2021 - 06/2002
24ixazomibIBA
04/2024 - 08/2014
23Monoclonal AntibodiesIBA
04/2024 - 09/2003
23Proteasome Endopeptidase Complex (Proteasome)IBA
04/2022 - 10/2002
21defibrotideIBA
02/2024 - 06/2007
19Proteins (Proteins, Gene)FDA Link
03/2024 - 05/2003
19Melphalan (Alkeran)FDA LinkGeneric
12/2023 - 03/2003
18PanobinostatIBA
11/2021 - 11/2011
17isatuximabIBA
04/2024 - 05/2018
15melflufenIBA
02/2024 - 01/2016
15Immunomodulating AgentsIBA
12/2023 - 04/2009
12Alkylating AgentsIBA
11/2023 - 08/2006
12NF-kappa B (NF-kB)IBA
04/2010 - 06/2002
11selinexorIBA
05/2024 - 01/2019
11Prednisone (Sone)FDA LinkGeneric
06/2019 - 08/2008
9elotuzumabIBA
01/2023 - 06/2012
8Peptides (Polypeptides)IBA
11/2023 - 06/2003
8Histone Deacetylase InhibitorsIBA
11/2021 - 04/2003
8Interleukin-6 (Interleukin 6)IBA
07/2010 - 08/2002
7carfilzomibIBA
04/2024 - 08/2014
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 04/2005
7CytokinesIBA
07/2010 - 03/2004
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2007 - 09/2002
6perifosineIBA
07/2020 - 05/2006
6DNA (Deoxyribonucleic Acid)IBA
01/2019 - 03/2003
5Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2014
5marizomibIBA
10/2020 - 01/2010
5CreatinineIBA
01/2019 - 01/2011
5Immunoglobulins (Immunoglobulin)IBA
01/2018 - 12/2007
5Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2015 - 10/2002
5Diphosphonates (Bisphosphonates)IBA
08/2014 - 07/2005
5Antineoplastic Agents (Antineoplastics)IBA
08/2013 - 06/2004
5VorinostatFDA Link
07/2013 - 04/2003
5tanespimycin (17AAG)IBA
06/2011 - 02/2006
4Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
03/2024 - 12/2009
4belantamab mafodotinIBA
12/2023 - 12/2018
4B-Cell Maturation AntigenIBA
09/2023 - 12/2018
4AminopeptidasesIBA
04/2022 - 09/2020
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2007 - 10/2003
3Cisplatin (Platino)FDA LinkGeneric
01/2021 - 04/2005
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 03/2003
3AntibodiesIBA
01/2021 - 08/2005
3Immunoconjugates (Immunoconjugate)IBA
10/2020 - 12/2018
3AntigensIBA
12/2018 - 06/2003
3Phosphotransferases (Kinase)IBA
06/2014 - 05/2004
3EnzymesIBA
01/2013 - 03/2004
3Transcription Factors (Transcription Factor)IBA
09/2012 - 06/2002
3GlucocorticoidsIBA
12/2007 - 01/2005

Therapy/Procedure

163Therapeutics
05/2024 - 04/2003
37Stem Cell Transplantation
12/2023 - 09/2005
19Drug Therapy (Chemotherapy)
03/2024 - 06/2003
14Hematopoietic Stem Cell Transplantation
11/2022 - 06/2007
12Transplantation
04/2024 - 09/2003
8Cell Transplantation
01/2023 - 09/2013
5Immunotherapy
01/2018 - 06/2003
4Radiotherapy
10/2020 - 05/2005
3Drug Tapering
06/2014 - 07/2006